The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
Open accessAbstract
HIV-1 protease inhibitors continue to play an important role in the treatment of HIV/AIDS, transforming this deadly ailment into a more manageable chronic infection. Over the years, intensive research has led to a variety of approved protease inhibitors for the treatment of HIV/AIDS. In this review, we outline current drug design and medicinal chemistry efforts toward the development of next-generation protease inhibitors beyond the currently approved drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J. E., Balfour, H. H., Deyton, L. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371101 · Cited by 2,640
Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371102 · Cited by 1,885
Isolation of Human T-Cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS)
Gallo, R. C., Sarin, P. S., Gelmann, E. P., Robert-Guroff, M., Richardson, E., Kalyanaraman, V. S., Mann, D., Sidhu, G. D., Stahl, R. E., Zolla-Pazner, S., et al. (1983) · Science · doi:10.1126/science.6601823 · Cited by 1,238
Pathways to neuronal injury and apoptosis in HIV-associated dementia
Kaul, M., Garden, G. A., & Lipton, S. A. (2001) · Nature · doi:10.1038/35073667 · Cited by 1,210
Conserved Folding in Retroviral Proteases: Crystal Structure of Synthetic HIV-1 Protease
Wlodawer, A., Miller, M., Jaskólski, M., Sathyanarayana, B. K., Baldwin, E., Weber, I. T., Selk, L. M., Clawson, L., Schneider, J., & Kent, S. B. H. (1989) · Science · doi:10.1126/science.2548279 · Cited by 1,168
Rational Design of Peptide-Based HIV Proteinase Inhibitors
Roberts, N. A., Martin, J. A., Kinchington, D., Broadhurst, A. V., Craig, J. C., Duncan, I. B., Galpin, S. A., Handa, B. K., Kay, J., Kröhn, A., et al. (1990) · Science · doi:10.1126/science.2183354 · Cited by 929
HIV infection: epidemiology, pathogenesis, treatment, and prevention
Maartens, G., Celum, C., & Lewin, S. R. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60164-1 · Cited by 830
Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease
Kaldor, S. W., Kalish, V. J., Davies, J. F., Shetty, B. V., Fritz, J. E., Appelt, K., Burgess, J. A., Campanale, K. M., Chirgadze, N. Y., Clawson, D. K., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9704098 · Cited by 618
Kempf, D. J., Marsh, K. C., Denissen, J. F., McDonald, E., Vasavanonda, S., Flentge, C. A., Green, B. E., Fino, L., Park, C. H., & Kong, X. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2484 · Cited by 560
Neurological complications of HIV infection
McArthur, J. C., Brew, B. J., & Nath, A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70165-4 · Cited by 554
Kozal, M. J., Shah, N., Shen, N., Yang, R., Fucini, R., Merigan, T. C., Richman, D. D., Morris, D., Hubbell, E., Chee, M., et al. (1996) · Nature Medicine · doi:10.1038/nm0796-753 · Cited by 527
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.
Vacca, J. P., Dorsey, B. D., Schleif, W. A., Levin, R. B., McDaniel, S. L., Darke, P. L., Zugay, J., Quintero, J. C., Blahy, O. M., & Roth, E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4096 · Cited by 527
Inhibitors of HIV‐1 Protease by Using In Situ Click Chemistry
Whiting, M., Muldoon, J., Lin, Y., Silverman, S. M., Lindstrom, W., Olson, A. J., Kolb, H. C., Finn, M. G., Sharpless, K. B., Elder, J. H., et al. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502161 · Cited by 516
Burger's Medicinal Chemistry and Drug Discovery
Abraham, D. J. (2003) · Wiley eBooks · doi:10.1002/0471266949 · Cited by 499
ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease
Sham, H. L., Kempf, D. J., Molla, A., Marsh, K. C., Kumar, G. N., Chen, C.-M., Kati, W., Stewart, K., Lal, R., Hsu, A., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3218 · Cited by 471
Lapatto, R., Blundell, T., Hemmings, A., Overington, J., Wilderspin, A., Wood, S., Merson, J. R., Whittle, P. J., Danley, D. E., Geoghegan, K. F., et al. (1989) · Nature · doi:10.1038/342299a0 · Cited by 456
HIV-1 protease: mechanism and drug discovery
Brik, A., & Wong, C.-H. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b208248a · Cited by 455
HIV protease inhibitors: a review of molecular selectivity and toxicity
Wang, Y., Lv, Z., & Chu, Y. (2015) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s79956 · Cited by 450
Condra, J. H., Holder, D. J., Schleif, W. A., Blahy, O. M., Danovich, R. M., Gabryelski, L. J., Graham, D. J., Laird, D., Quintero, J. C., Rhodes, A., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8270-8276.1996 · Cited by 405
Kim, E. E., Baker, C. T., Dwyer, M. D., Murcko, M. A., Rao, B. G., Tung, R. D., & Navia, M. A. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00108a056 · Cited by 390
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
Mehellou, Y., & De Clercq, E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900492g · Cited by 368
Koh, Y., Nakata, H., Maeda, K., Ogata, H., Bilcer, G., Devasamudram, T., Kincaid, J. F., Boross, P., Wang, Y.-F., Tie, Y., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3123-3129.2003 · Cited by 367
Self-citationKumar, G. N., Rodrigues, A. D., Buko, A. M., & Denissen, J. F. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12840-1 · Cited by 353
Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
Wensing, A. M. J., van Maarseveen, N. M., & Nijhuis, M. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.003 · Cited by 339
Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus
Kramer-Hämmerle, S., Rothenaigner, I., Wolff, H., Bell, J. E., & Brack-Werner, R. (2005) · Virus Research · doi:10.1016/j.virusres.2005.04.009 · Cited by 335
Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends: Miniperspective
Zhan, P., Pannecouque, C., De Clercq, E., & Liu, X. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00497 · Cited by 303
Defeating AIDS—advancing global health
Piot, P., Abdool Karim, S. S., Hecht, R., Legido-Quigley, H., Buse, K., Stover, J., Resch, S., Ryckman, T., Møgedal, S., Dybul, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60658-4 · Cited by 293
1,2,3‐Triazole as a Peptide Surrogate in the Rapid Synthesis of HIV‐1 Protease Inhibitors
Brik, A., Alexandratos, J., Lin, Y., Elder, J. H., Olson, A. J., Wlodawer, A., Goodsell, D. S., & Wong, C. (2005) · ChemBioChem · doi:10.1002/cbic.200500101 · Cited by 283
Gulnik, S. V., Suvorov, L. I., Liu, B., Yu, B., Anderson, B., Mitsuya, H., & Erickson, J. W. (1995) · Biochemistry · doi:10.1021/bi00029a002 · Cited by 260
(2023) · Advances in Pharmacology · doi:10.1016/s1054-3589(23)00038-8 · Cited by 251
A brief history of antiretroviral therapy of HIV infection: success and challenges.
Palmisano, L., & Vella, S. (2011) · PubMed · doi:10.4415/ann_11_01_10 · Cited by 234
Krohn, A., Redshaw, S., Ritchie, J. C., Graves, B. J., & Hatada, M. H. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00115a028 · Cited by 233
Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV
Ghosh, A. K., Dawson, Z. L., & Mitsuya, H. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.09.010 · Cited by 230
Self-citationExpression and Processing of the AIDS Virus Reverse Transcriptase in Escherichia coli
Farmerie, W. G., Loeb, D. D., Casavant, N. C., Hutchison, C. A., Edgell, M. H., & Swanstrom, R. (1987) · Science · doi:10.1126/science.2436298 · Cited by 203
Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer
Xu, L., Liu, H., Murray, B. P., Callebaut, C., Lee, M. S., Hong, A., Strickley, R. G., Tsai, L. K., Stray, K. M., Wang, Y., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1000257 · Cited by 195
The structural stability of the HIV-1 protease 1 1Edited by P. E. Wright
Todd, M. J., Semo, N., & Freire, E. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2090 · Cited by 166
Koh, Y., Matsumi, S., Das, D., Amano, M., Davis, D. A., Li, J., Leschenko, S., Baldridge, A., Shioda, T., Yarchoan, R., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703938200 · Cited by 161
Self-citationEnhancing Protein Backbone Binding—A Fruitful Concept for Combating Drug‐Resistant HIV
Ghosh, A. K., Anderson, D. D., Weber, I. T., & Mitsuya, H. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201102762 · Cited by 155
Self-citationOhtaka, H., Schön, A., & Freire, E. (2003) · Biochemistry · doi:10.1021/bi0350405 · Cited by 142
Graves, M. C., Lim, J. J., Heimer, E. P., & Kramer, R. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2449 · Cited by 137
Dine, R. S. E., Halawany, A. M. E., Ma, C., & Hattori, M. (2008) · Journal of Natural Products · doi:10.1021/np8001139 · Cited by 124
Perno, C. F., Cozzi‐Lepri, A., Balotta, C., Forbici, F., Violin, M., Bertoli, A., Facchi, G., Pezzotti, P., Cadeo, G., Tositti, G., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/323604 · Cited by 124
Prabu-Jeyabalan, M., Nalivaika, E. A., King, N. M., & Schiffer, C. A. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1306-1315.2003 · Cited by 122
Nalam, M. N. L., Ali, A., Altman, M. D., Reddy, G. S., Chellappan, S., Kairys, V., Özen, A., Cao, H., Gilson, M. K., Tidor, B., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02531-09 · Cited by 120
Hué, S., Gifford, R. J., Dunn, D. T., Fernhill, E., & Pillay, D. (2009) · Journal of Virology · doi:10.1128/jvi.01556-08 · Cited by 114
Olomola, T. O., Klein, R., Mautsa, N., Sayed, Y., & Kaye, P. T. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.01.025 · Cited by 111
Kožíšek, M., Bray, J. K., Řezáčová, P., Šašková, K. G., Brynda, J., Pokorná, J., Mammano, F., Rulíšek, L., & Konvalinka, J. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.09.083 · Cited by 95
Koh, Y., Amano, M., Towata, T., Danish, M. L., Leshchenko, S., Das, D., Nakayama, M., Tojo, Y., Ghosh, A. K., & Mitsuya, H. (2010) · Journal of Virology · doi:10.1128/jvi.00967-10 · Cited by 95
Self-citationYarchoan, R., Lietzau, J., Nguyen, B., Brawley, O. W., Pluda, J. M., Saville, M. W., Wyvill, K. M., Steinberg, S. M., Agbaria, R., Mitsuya, H., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.1.9 · Cited by 90
Hayashi, H., Takamune, N., Nirasawa, T., Aoki, M., Morishita, Y., Das, D., Koh, Y., Ghosh, A. K., Misumi, S., & Mitsuya, H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400027111 · Cited by 86
Self-citationMahalingam, B., Wang, Y., Boross, P. I., Tőzsér, J., Louis, J. M., Harrison, R. W., & Weber, I. T. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04060.x · Cited by 76
Energy calculations and analysis of HIV-1 protease-inhibitor crystal structures
Gustchina, A., Sansom, C., Prévost, M., Richelle, J., Wodak, S. J., Wlodawer, A., & Weber, I. T. (1994) · Protein Engineering Design and Selection · doi:10.1093/protein/7.3.309 · Cited by 76
New Antivirals and Drug Resistance
Colman, P. M. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082207.084029 · Cited by 75
Design of HIV-1 Protease Inhibitors Active on Multidrug-Resistant Virus
Surleraux, D. L. N. G., de Kock, H. A., Verschueren, W. G., Pille, G. M. E., Maes, L. J. R. M., Peeters, A., Vendeville, S., Meyer, S. D., Azijn, H., Pauwels, R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049454n · Cited by 73
Olomola, T. O., Klein, R., Lobb, K. A., Sayed, Y., & Kaye, P. T. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.09.121 · Cited by 72
Ghosh, A. K., Chapsal, B. D., Baldridge, A., Steffey, M., Walters, D. E., Koh, Y., Amano, M., & Mitsuya, H. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1012787 · Cited by 71
Self-citationAmano, M., Koh, Y., Das, D., Li, J., Leschenko, S., Wang, Y.-F., Boross, P. I., Weber, I. T., Ghosh, A. K., & Mitsuya, H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01413-06 · Cited by 70
Self-citationNew 2-bromomethyl-8-substituted-benzo[c]chromen-6-ones. Synthesis and biological properties
Garino, C., Bihel, F. J. ‐., Pietrancosta, N., Laras, Y., Quéléver, G., Woo, I., Klein, P. S., Bain, J., Boucher, J., & Kraus, J. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.10.018 · Cited by 66
Structure-Aided Design of Novel Inhibitors of HIV Protease Based on a Benzodiazepine Scaffold
Schimer, J., Cígler, P., Veselý, J., Šašková, K. G., Lepšı́k, M., Brynda, J., Řezáčová, P., Kožíšek, M., Cı́sařová, I., Oberwinkler, H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301249q · Cited by 66
Anti-HIV-1 protease triterpenoids from Stauntonia obovatifoliola Hayata subsp. intermedia
Wei, Y. J., Ma, C., Chen, D., & Hattori, M. (2008) · Phytochemistry · doi:10.1016/j.phytochem.2008.03.004 · Cited by 63
Lee, J., Miyashiro, H., Nakamura, N., & Hattori, M. (2008) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.56.711 · Cited by 59
Ali, A., Reddy, G. S., Nalam, M. N. L., Anjum, S. G., Cao, H., Schiffer, C. A., & Rana, T. M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1008743 · Cited by 55
Laco, G. S., Schalk‐Hihi, C., Lubkowski, J. T., Morris, G. M., Zdanov, A. S., Olson, A. J., Elder, J. H., Wlodawer, A., & Gustchina, A. (1997) · Biochemistry · doi:10.1021/bi9707436 · Cited by 55
Development of Protease Inhibitors and the Fight with Drug‐Resistant HIV‐1 Variants
Mitsuya, H., Maeda, K., Das, D., & Ghosh, A. K. (2008) · Advances in pharmacology · doi:10.1016/s1054-3589(07)56006-0 · Cited by 54
Self-citationParai, M. K., Huggins, D. J., Cao, H., Nalam, M. N. L., Ali, A., Schiffer, C. A., Tidor, B., & Rana, T. M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300238h · Cited by 50
Koh, Y., Aoki, M., Danish, M. L., Aoki-Ogata, H., Amano, M., Das, D., Shafer, R. W., Ghosh, A. K., & Mitsuya, H. (2011) · Journal of Virology · doi:10.1128/jvi.05121-11 · Cited by 48
Self-citationDiscovery of potent HIV-1 protease inhibitors incorporating sulfoximine functionality
Ding, L., & Vince, R. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.095 · Cited by 44
Ekegren, J. K., Ginman, N., Johansson, Å., Wallberg, H., Larhed, M., Samuelsson, B., Unge, T., & Hallberg, A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051239z · Cited by 44
Ding, L., Sham, Y. Y., & Vince, R. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.01.020 · Cited by 41
Design of the anti-HIV protease inhibitor darunavir
Ghosh, A. K., & Chapsal, B. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397176-0.00013-3 · Cited by 37
Self-citationInhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease
Davis, D. A., Brown, C. A., Singer, K. E., Wang, V., Kaufman, J. D., Stahl, S. J., Wingfield, P. T., Maeda, K., Harada, S., Yoshimura, K., et al. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.03.015 · Cited by 36
Goldfarb, N. E., Ohanessian, M., Biswas, S., McGee, T. D., Mahon, B. P., Ostrov, D. A., Garcia, J., Tang, Y. B., McKENNA, R. V., Roitberg, A. E., et al. (2014) · Biochemistry · doi:10.1021/bi501088e · Cited by 35
Ghosh, A. K., Martyr, C. D., Steffey, M., Wang, Y.-F., Agniswamy, J., Amano, M., Weber, I. T., & Mitsuya, H. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100289m · Cited by 31
Self-citationSalcedo-Gómez, P. M., Amano, M., Yashchuk, S., Mizuno, A., Das, D., Ghosh, A. K., & Mitsuya, H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01420-13 · Cited by 25
Self-citationGhosh, A. K., Yashchuk, S., Mizuno, A., Chakraborty, N., Agniswamy, J., Wang, Y., Aoki, M., Salcedo-Gómez, P. M., Amano, M., Weber, I. T., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201402358 · Cited by 23
Self-citationWu, X., Öhrngren, P., Joshi, A. A., Trejos, A., Persson, M., Arvela, R. K., Wallberg, H., Vrang, L., Rosenquist, Å., Samuelsson, B., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201620t · Cited by 23
Disubstituted Bis-THF Moieties as New P2 Ligands in Nonpeptidal HIV-1 Protease Inhibitors (II)
Hohlfeld, K., Wegner, J. K., Kesteleyn, B., Linclau, B., & Unge, J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00358 · Cited by 21
Vidu, A., Dufau, L., Bannwarth, L., Soulier, J. L., Sicsic, S., Piarulli, U., Reboud‐Ravaux, M., & Ongeri, S. (2010) · ChemMedChem · doi:10.1002/cmdc.201000308 · Cited by 20
Chang, Y.-C. E., Yu, X., Zhang, Y., Tie, Y., Wang, Y.-F., Yashchuk, S., Ghosh, A. K., Harrison, R. W., & Weber, I. T. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300072d · Cited by 18
Self-citationQiu, X., Zhao, G., Tang, L.-Q., & Liu, Z. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.008 · Cited by 15
Ghosh, A. K., Martyr, C. D., Osswald, H. L., Sheri, V. R., Kassekert, L. A., Chen, S., Agniswamy, J., Wang, Y.-F., Hayashi, H., Aoki, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00900 · Cited by 15
Self-citationYan, J., Huang, N., Li, S., Yang, L., Xing, W., Zheng, Y., & Hu, Y. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.037 · Cited by 14
Öhrngren, P., Wu, X., Persson, M., Ekegren, J. K., Wallberg, H., Vrang, L., Rosenquist, Å., Samuelsson, B., Unge, T., & Larhed, M. (2011) · MedChemComm · doi:10.1039/c1md00077b · Cited by 13
First‐Generation HIV‐1 Protease Inhibitors for the Treatment of HIV/AIDS
Virgil, S. C. (2010) · Methods and principles in medicinal chemistry · doi:10.1002/9783527630943.ch6 · Cited by 9
Gao, B., Zhang, C., Yin, Y., Tang, L.-Q., & Liu, Z. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.04.070 · Cited by 7
Recovery of the wild type atomic flexibility in the HIV-1 protease double mutants
Conto, V. D., Braz, A. S. K., Pérahia, D., & Scott, A. L. (2015) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2015.04.006 · Cited by 3
Cited by
An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
Owen, D. R., Allerton, C. M. N., Anderson, A. S., Aschenbrenner, L., Avery, M., Berritt, S., Boras, B., Cardin, R. D., Carlo, A., Coffman, K. J., et al. (2021) · Science · doi:10.1126/science.abl4784 · Cited by 2,033
A Structure-Based Drug Discovery Paradigm
Batool, M., Ahmad, B., & Choi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112783 · Cited by 744
Therapeutic strategies for COVID-19: progress and lessons learned
Li, G., Hilgenfeld, R., Whitley, R., & De Clercq, E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00672-y · Cited by 676
Peptidomimetic toolbox for drug discovery
Lenci, E., & Trabocchi, A. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00102c · Cited by 326
Cryo-EM structure of the HIV-1 Pol polyprotein provides insights into virion maturation
Harrison, J. J. E. K., Passos, D. O., Bruhn, J. F., Bauman, J. D., Tuberty, L., DeStefano, J. J., Ruiz, F. X., Lyumkis, D., & Arnold, E. (2022) · Science Advances · doi:10.1126/sciadv.abn9874 · Cited by 31
“These structures have helped in the development of antiretroviral drugs ( 17 – 19 ).”
Metadata
- Authors
- Ghosh, A. K., Osswald, H. L., & Prato, G.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-01-22
- Volume
- 59
- Issue
- 11
- Pages
- 5172-5208
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2345988829
- Cited by
- 419
- References
- 87
- FWCI
- 29.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.